Patents by Inventor Paul Neeson

Paul Neeson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-PVRIG AND ANTI-TIGIT ANTIBODIES FOR ENHANCED NK-CELL BASED TUMOR KILLING
    Publication number: 20230057899
    Abstract: Anti-PVRIG and anti-TIGIT for use in methods of treatment based on the enhanced NK-cell using the antibodies for the treatment of cancer.
    Type: Application
    Filed: December 7, 2020
    Publication date: February 23, 2023
    Inventors: Maya Kotturi, Sarah Whelan, Paul Neeson, Jessica Li, Joseph A. Trapani, Eran Ophir, Moran Galperin
  • Compositions and methods for treatment of non-hodgkins lymphoma
    Patent number: 10166276
    Abstract: The present invention provides recombinant peptides comprising a B cell receptor (BCR) or a fragment thereof, nucleotide molecules encoding same, and vaccines and vectors comprising same; and methods of treating, inducing an immune response against, inducing a regression of, and suppressing a formation of a lymphoma, comprising administering same. The present invention also provides methods of inducing a humoral immune response in an animal against an antigen, comprising administering to the animal a fusion peptide comprising an LLO protein or fragment thereof fused to the antigen.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: January 1, 2019
    Assignee: The Trustees of the University of Philadelphia
    Inventors: Yvonne Paterson, Paul Neeson
  • Stimulating immune response
    Patent number: 9724329
    Abstract: Methods of treatment or prevention of a cancerous or pre-cancerous condition, of slowing or preventing growth of a cancerous condition, of stimulating a cell-mediated immune response, stimulating a Th1 helper T cell response against a pathogen in a mammal and of treating or preventing inflammatory diseases or disorders that involve administration of N-methyl pyrrolidone (NMP) or a physiologically acceptable salt, solvate, tautomer or prodrug thereof are provided. Also provided are formulations of an active agent.
    Type: Grant
    Filed: June 21, 2011
    Date of Patent: August 8, 2017
    Assignee: Peter MacCallum Cancer Institute
    Inventors: Andy Kang-Wei Hsu, Jake Shortt, Paul Neeson, Ricky Wayne Johnstone, David Ritchie
  • COMPOSITIONS AND METHODS FOR TREATMENT OF NON-HODGKINS LYMPHOMA
    Publication number: 20160158331
    Abstract: The present invention provides recombinant peptides comprising a B cell receptor (BCR) or a fragment thereof, nucleotide molecules encoding same, and vaccines and vectors comprising same; and methods of treating, inducing an immune response against, inducing a regression of, and suppressing a formation of a lymphoma, comprising administering same. The present invention also provides methods of inducing a humoral immune response in an animal against an antigen, comprising administering to the animal a fusion peptide comprising an LLO protein or fragment thereof fused to the antigen.
    Type: Application
    Filed: July 11, 2014
    Publication date: June 9, 2016
    Inventors: Yvonne PATERSON, Paul Neeson
  • Compositions and methods for treatment of non-hodgkins lymphoma
    Patent number: 8791237
    Abstract: The present invention provides recombinant peptides comprising a B cell receptor (BCR) or a fragment thereof, nucleotide molecules encoding same, and vaccines and vectors comprising same; and methods of treating, inducing an immune response against, inducing a regression of, and suppressing a formation of a lymphoma, comprising administering same. The present invention also provides methods of inducing a humoral immune response in an animal against an antigen, comprising administering to the animal a fusion peptide comprising an LLO protein or fragment thereof fused to the antigen.
    Type: Grant
    Filed: May 2, 2006
    Date of Patent: July 29, 2014
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Yvonne Paterson, Paul Neeson
  • STIMULATING IMMUNE RESPONSE
    Publication number: 20130302377
    Abstract: Methods of treatment or prevention of a cancerous or pre-cancerous condition, of slowing or preventing growth of a cancerous condition, of stimulating a cell-mediated immune response, stimulating a Th1 helper T cell response against a pathogen in a mammal and of treating or preventing inflammatory diseases or disorders that involve administration of N-methyl pyrrolidone (NMP) or a physiologically acceptable salt, solvate, tautomer or prodrug thereof are provided. Also provided are formulations of an active agent.
    Type: Application
    Filed: June 21, 2011
    Publication date: November 14, 2013
    Applicant: PETER MACCALLUM CANCER INSTITUTE
    Inventors: Andy Kang-Wei Hsu, Jake Shortt, Paul Neeson, Ricky Wayne Johnstone, David Ritchie
  • Compositions and methods for treatment of non-hodgkins lymphoma
    Publication number: 20060269561
    Abstract: The present invention provides recombinant peptides comprising a B cell receptor (BCR) or a fragment thereof, nucleotide molecules encoding same, and vaccines and vectors comprising same; and methods of treating, inducing an immune response against, inducing a regression of, and suppressing a formation of a lymphoma, comprising administering same. The present invention also provides methods of inducing a humoral immune response in an animal against an antigen, comprising administering to the animal a fusion peptide comprising an LLO protein or fragment thereof fused to the antigen.
    Type: Application
    Filed: May 2, 2006
    Publication date: November 30, 2006
    Inventors: Yvonne Paterson, Paul Neeson